Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Carboplatin × CNS × Clear all

Phase

Phase 2 57 Phase 3 29 Phase 1/2 22 Phase 1 20 Phase NA 7 Phase 2/3 3 Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 4 Thoracic 3 Breast 3 Genitourinary 2 Gastrointestinal 2 Sarcoma 1 Lymphoid 1 Head & Neck 1 CNS 1

Conditions

Glioma 1 Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 15 Temozolomide 14 Radiotherapy 9 fluciclovine F-18 6 Specimen Handling 6 Bevacizumab 6 fluorodopa F 18 4 Topotecan 4 Irinotecan 4 Fluorodeoxyglucose F18 4 Ferrosoferric Oxide 4 Biopsy 4 gallium Ga 68 dotatate 3 abemaciclib 3 Radiation 3 Pemetrexed 3 Methotrexate 3 Ketoconazole 3 Everolimus 3 Cyclophosphamide 3 posaconazole 2 poly ICLC 2 olaparib 2 niraparib 2 Vincristine 2 Tissue Array Analysis 2 Therapeutics 2 Surgical Procedures, Operative 2 Standard of Care 2 Rituximab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02279992 2017-09-11

LevitraCarbo

Cedars-Sinai Medical Center

Phase EARLY_PHASE1 Terminated

Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡